Company intelligence / Profile preview

苏州迈德通医药科技有限公司

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Suzhou Medton Pharmaceutical Technology is a specialized pharmaceutical company focused on the research, development, and manufacturing of inhalation drug delivery systems. Based in the Suzhou Industrial Park, the company provides comprehensive CRO and CDMO services for complex formulations, including dry powder inhalers (DPI), metered-dose inhalers (MDI), and nasal sprays. Medton leverages its proprietary technology platforms to develop high-quality respiratory medicines for asthma and COPD. Their expertise spans from device design and formulation optimization to clinical supply and commercial production.

Therapeutic areas: PulmonologyImmunology
Modalities: Small moleculeDevice
Industry: Biotech

Beyond the preview

Go deeper on 苏州迈德通医药科技有限公司.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 苏州迈德通医药科技有限公司.

Explore the full profile